HON's Aerospace Technologies segment rose 6% in Q2 on surging defense and aviation demand, with more growth forecast for 2025.
JOBY moves to acquire Blade's passenger business for up to $125 million, aiming to scale urban air mobility and cut costs.
CMG's rapid expansion continues, but flat same-store sales, rising competition and market headwinds raise tough questions about sustainability.
JNJ's Innovative Medicine unit posts solid Q2 growth despite Stelara's LOE, powered by Darzalex, Tremfya, Erleada and new drugs.
The search giant is spending tens of billions of dollars on infusing its products with artificial intelligence capabilities.
AON's Q2 results are expected to gain on new business growth in Commercial Risk Solutions and Health Solutions businesses, partly offset by escalating compensation and benefits costs.
ASTL begins steel production at Canada's largest industrial decarbonization project, launching its low-emission Volta product line.
DB revamps its German wealth unit, merging client services and adding digital tools to drive growth.
AXON's Connected Devices segment surges 26.1% in Q1 2025, fueled by strong TASER 10 and Axon Body 4 demand.
LMT's $92.2M Navy contract will enhance AEGIS sustainment, field new capabilities and boost integrated defense tech.
ANET's VeloCloud buyout adds 20K clients and proven SD-WAN tech, boosting its edge in secure cloud networking.
JNJ is banking on Darzalex, Tremfya and new drugs to offset Stelara's LOE and Part D headwinds in Q2 Innovative Medicine sales.